Boundless Bio

Filed a patent for "uses of a checkpoint kinase 1 (chk1) inhibitor" on Mon, March 20, 2023

Filed a patent for "checkpoint kinase 1 (chk1) inhibitor pharmaceutical composition" on Mon, April 3, 2023

Filed a patent for "checkpoint kinase 1 (chk1) inhibitor crystalline form and uses thereof" on Mon, April 3, 2023

Filed a patent for "uses of a checkpoint kinase 1 (chk1) inhibitor" on Wed, October 18, 2023

Filed a patent for "uses of a checkpoint kinase 1 (chk1) inhibitor" on Mon, January 22, 2024

Filed a patent for "uses of a checkpoint kinase 1 (chk1) inhibitor" on Mon, February 26, 2024

Filed a patent for "cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof" on Fri, March 15, 2024

Filed a patent for "phenol ribonucleotide reductase (rnr) inhibitors and uses thereof" on Thu, August 29, 2024

Filed a patent for "sulfamide ribonucleotide reductase (rnr) inhibitors and uses thereof" on Fri, March 15, 2024

Filed a patent for "wee1 inhibitors and uses thereof" on Thu, December 22, 2022

Filed a patent for "wee1 inhibitors and uses thereof" on Thu, July 11, 2024

Filed a patent for "method of identifying extrachromosomal dna signatures" on Thu, April 6, 2023

Filed a patent for "pyridine checkpoint kinase 1 (chk1) inhibitors and uses thereof" on Tue, November 29, 2022

Filed a patent for "replication stress pathway agent compositions and methods for treating cancer" on Thu, August 31, 2023

Filed a patent for "replication stress pathway agent compositions and methods for treating cancer" on Thu, August 10, 2023

Filed a patent for "checkpoint kinase 1 (chk1) inhibitors and uses thereof" on Thu, October 5, 2023

Filed a patent for "ribonucleotide reductase (rnr) inhibitors and uses thereof" on Thu, May 16, 2024

Filed a patent for "pyridine checkpoint kinase 1 (chk1) inhibitors and uses thereof" on Tue, May 24, 2022

Filed a patent for "checkpoint kinase 1 (chk1) inhibitors and uses thereof" on Thu, January 26, 2023

Filed a patent for "cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof" on Tue, September 13, 2022

Filed a patent for "computer-implemented methods for quantitation of features of interest in whole-slide imaging" on Thu, April 20, 2023

Filed a patent for "replication stress pathway agent compositions and methods for treating cancer" on Thu, March 16, 2023